Per Nilsson
1 – 10 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
MRI-only radiotherapy from an economic perspective : Can new techniques in prostate cancer treatment be cost saving?
Persson, Emilia LU ; Svanberg, Niklas ; Scherman, Jonas ; Jamtheim Gustafsson, Christian LU ; Fridhammar, Adam ; Hjalte, Frida ; Bäck, Sven LU ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
and Olsson, Lars E
LU
(2023)
In Clinical and Translational Radiation Oncology
38.
p.183-187
- Contribution to journal › Article
- 2022
-
Mark
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy - The PROPER 1 trial
- Contribution to journal › Article
-
Mark
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
Adrian, Gabriel LU
; Carlsson, Henrik
LU
; Kjellén, Elisabeth
LU
; Sjövall, Johanna
LU
; Zackrisson, Björn
; Nilsson, Per
LU
and Gebre-Medhin, Maria
LU
(2022)
In Radiation Oncology
17(1).
- Contribution to journal › Article
-
Mark
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
Wennerberg, Johan LU
; Gebre-Medhin, Maria
LU
; Nilsson, Per
LU
; Brun, Eva
LU
; Kjellén, Elisabeth
LU
; Carlwig, Kristin
LU
; Reizenstein, Johan
; Kristiansson, Stefan
; Söderkvist, Karin
and Wahlgren, Magnus
, et al.
(2022)
In Radiotherapy and Oncology
166.
p.26-32
- Contribution to journal › Article
- 2021
-
Mark
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer : A Dose-Response Study
Rasmusson, Elisabeth LU ; Nilsson, Per LU
; Kjellén, Elisabeth
LU
and Gunnlaugsson, Adalsteinn
LU
(2021)
In Advances in Radiation Oncology
6(1).
- Contribution to journal › Article
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
- Contribution to journal › Article
-
Mark
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
Jóhannesson, Vilberg LU ; Wieslander, Elinore LU ; Nilsson, Per LU
; Brun, Eva
LU
; Bitzén, Ulrika
LU
; Ahlgren, Göran
LU
; Olsson, Tomas
LU
; Bäck, Sven
LU
; Kjellén, Elisabeth
LU
and Gunnlaugsson, Adalsteinn
LU
(2021)
In Physics and imaging in radiation oncology
18.
p.5-10
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Fransson, Per ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Beckman, Lars
; Tavelin, Björn
; Norman, David
; Thellenberg-Karlsson, Camilla
; Hoyer, Morten
; Lagerlund, Magnus
and Kindblom, Jon
, et al.
(2021)
In The Lancet Oncology
22(2).
p.235-245
- Contribution to journal › Article
- 2020
-
Mark
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery : 20-Year Follow-up of the Randomized SweBCGRT Trial
- Contribution to journal › Article
-
Mark
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
Rasmusson, Elisabeth LU ; Gunnlaugsson, Adalsteinn LU ; Wieslander, Elinore LU ; Höglund, Peter LU ; Widmark, Anders ; Fransson, Per ; Kjellén, Elisabeth LU and Nilsson, Per LU
(2020)
In International Journal of Radiation Oncology Biology Physics
107(1).
p.143-151
- Contribution to journal › Article